Squarepoint Ops LLC Mirati Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$59.6 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $157,158 - $233,372	-4,301 Reduced 13.24%	28,189 $1.05 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $1.34 Million - $3.2 Million	32,490 New	32,490 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $2.6 Million - $5.89 Million	66,382 Added 1047.03%	72,722 $4.88 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $480,698 - $957,149	6,340 New	6,340 $521,000
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $237,750 - $342,712	-1,801 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $1.13 Million - $1.51 Million	-8,529 Reduced 82.57%	1,801 $319,000
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $1.49 Million - $1.86 Million	10,330 New	10,330 $1.67 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $803,817 - $1.12 Million	-5,058 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $819,648 - $1.22 Million	5,058 New	5,058 $1.11 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $759,136 - $1.26 Million	-10,879 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $769,798 - $1.4 Million	10,879 New	10,879 $1.4 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $786,891 - $1.11 Million	-10,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $4.33 Million - $7.63 Million	-72,824 Reduced 87.82%	10,100 $1.04 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $2.47 Million - $4.46 Million	56,545 Added 214.36%	82,924 $6.08 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $844,128 - $1.25 Million	26,379 New	26,379 $1.12 Million
Q2 2018 Aug 14, 2018	SELL	$26.05 - $52.4 $369,910 - $744,080	-14,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $244,240 - $496,290	14,200 New	14,200 $436,000
Q4 2017 Feb 14, 2018	SELL	$12.65 - $19.0 $265,333 - $398,525	-20,975 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $98,582 - $245,407	20,975	20,975 $245,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account